1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CYTOMX THERAPEUTICS INC
CytomX Therapeutics Inc XNAS: CTMX

CytomX Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

Read More
3.88 0.02 (0.52%)
870.00% Gain from 52W Low
3.7M
XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
39.2 / 100
Momentum Score
Technically Moderately Bullish
69.1 / 100
Momentum Trap These stocks are with bad quality but mid-range Valuation. However, their good technical scoring may generate some interest amongst the audience. View Similar Embed DVM
Analyst Price Target
7
1Yr Price target upside is 82%
7 analysts

17

S

11

W

2

O

2

T

SWOT Analysis

CytomX Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..